All Stories

  1. Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia

    Article • Journal of Psychopharmacology, June 2019, SAGE Publications

    Dr Luis F Callado, Stephen Alexander

  2. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment

    Article • Neuropharmacology, November 2014, Elsevier

    Dr Luis F Callado

  3. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: Differential effect of antidepressant treatment

    Article • Journal of Affective Disorders, October 2014, Elsevier

    Dr Luis F Callado

  4. Recent cocaine use is a significant risk factor for sudden cardiovascular death in 15-49-year-old subjects: a forensic case-control study

    Article • Addiction, August 2014, Wiley

    Dr Luis F Callado

  5. The endocannabinoid system is altered in the post‐mortem prefrontal cortex of alcoholic subjects

    Article • Addiction Biology, July 2014, Wiley

    Dr Luis F Callado, Professor Javier Fernández-Ruiz, Stephen Alexander

  6. Guanidine-based α2-adrenoceptor ligands: Towards selective antagonist activity

    Article • European Journal of Medicinal Chemistry, July 2014, Elsevier

    Dr Luis F Callado

  7. ¿Qué aportan a la Psiquiatría los estudios en cerebro post mórtem?

    Article • Revista de Psiquiatría y Salud Mental, July 2014, Elsevier

    Dr Luis F Callado

  8. Do post-mortem brain studies provide useful information for Psychiatry?

    Article • Revista de Psiquiatría y Salud Mental (English Edition), July 2014, Elsevier

    Dr Luis F Callado

  9. Alcohol-Related Brain Damage in Humans

    Article • PLoS ONE, April 2014, PLOS

    Dr Luis F Callado

  10. Compounds combining pharmacophoric elements of CB1 and opioid mu.

    Article • Drug Design Development and Therapy, February 2014, Taylor & Francis

    Dr Luis F Callado, Dr. Nadine jagerovic, Luis F Callado

  11. Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects

    Article • European Neuropsychopharmacology, August 2013, Elsevier

    Dr Luis F Callado

  12. Quantification of endocannabinoids in postmortem brain of schizophrenic subjects

    Article • Schizophrenia Research, August 2013, Elsevier

    Dr Luis F Callado

  13. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain

    Article • European Journal of Pharmacology, June 2013, Elsevier

    Dr Luis F Callado

  14. Antidepressant-like properties of three new α2-adrenoceptor antagonists

    Article • Neuropharmacology, February 2013, Elsevier

    Dr Luis F Callado

  15. Description of a Bivalent Cannabinoid Ligand with Hypophagic Properties

    Article • Archiv der Pharmazie, February 2013, Wiley

    Dr Luis F Callado, Dr Francisco Javier Bermudez-Silva, Dr. Nadine jagerovic

  16. Chronic Effects of Cannabinoid Drugs on Monoaminergic Systems and the Role of Endocannabinoids and Cannabinoid Receptors in Human Brain Disorders

    Article • January 2013, Springer Science + Business Media

    Dr Luis F Callado

  17. A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia

    Article • Journal of Psychiatric Research, November 2012, Elsevier

    Dr Luis F Callado

  18. Neurological Soft Signs in Patients with Psychosis and Cannabis Abuse: A Systematic Review and Meta-Analysis of Paradox

    Article • Current Pharmaceutical Design, September 2012, Bentham Science Publishers

    Dr Luis F Callado

  19. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

    Article • Nature Neuroscience, August 2012, Springer Science + Business Media

    Dr Luis F Callado

  20. Screening and quantification of antipsychotic drugs in human brain tissue by liquid chromatography–tandem mass spectrometry: Application to postmortem diagnostics of forensic interest

    Article • Forensic Science International, June 2012, Elsevier

    Dr Luis F Callado

  21. Genetic Regulation of Emotion Brain Circuitries

    Article • September 2011, Taylor & Francis

    Dr Luis F Callado

  22. Involvement of the endocannabinoid system in alcohol dependence: The biochemical, behavioral and genetic evidence

    Article • Drug and Alcohol Dependence, September 2011, Elsevier

    Dr Luis F Callado

  23. Levels of Gsα(short and long), Gαolf and Gβ(common) subunits, and calcium-sensitive adenylyl cyclase isoforms (1, 5/6, 8) in post-mortem human brain caudate and cortical membranes: Comparison with rat brain membranes and potential stoichiometric relati...

    Article • Neurochemistry International, February 2011, Elsevier

    Dr Luis F Callado, Dr Joan Sallés

  24. Sistema gabaérgico y canales iónicos

    Article • January 2011, Elsevier

    Dr Luis F Callado

  25. Gliomas: Role of Monoamine Oxidase B in Diagnosis

    Article • January 2011, Springer Science + Business Media

    Dr Luis F Callado

  26. In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by α2-adrenoceptor antagonism

    Article • European Neuropsychopharmacology, November 2010, Elsevier

    Dr Luis F Callado

  27. Gi protein coupling to adenosine A1–A2A receptor heteromers in human brain caudate nucleus

    Article • Journal of Neurochemistry, July 2010, Wiley

    Dr Luis F Callado, Dr Joan Sallés

  28. Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas

    Article • Neurochemistry International, May 2010, Elsevier

    Dr Luis F Callado, Dr Joan Sallés

  29. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment

    Article • Psychopharmacology, August 2009, Springer Science + Business Media

    Dr Luis F Callado

  30. Guanidine and 2-Aminoimidazoline Aromatic Derivatives as α2-Adrenoceptor Ligands: Searching for Structure−Activity Relationships

    Article • Journal of Medicinal Chemistry, January 2009, American Chemical Society (ACS)

    Dr Luis F Callado

  31. A follow-up investigation on the quality of medical documents from examinations of Basque incommunicado detainees

    Article • Forensic Science International, November 2008, Elsevier

    Dr Luis F Callado

  32. El sistema noradrenérgico en la neurobiología de la depresión

    Article • Psiquiatría Biológica, October 2008, Elsevier

    Dr Luis F Callado

  33. Novel synthesis and pharmacological evaluation as α2-adrenoceptor ligands of O-phenylisouronium salts

    Article • Bioorganic & Medicinal Chemistry, September 2008, Elsevier

    Dr Luis F Callado

  34. Guanidine and 2-Aminoimidazoline Aromatic Derivatives as α2-Adrenoceptor Antagonists. 2. Exploring Alkyl Linkers for New Antidepressants

    Article • Journal of Medicinal Chemistry, May 2008, American Chemical Society (ACS)

    Dr Luis F Callado

  35. Identification of a serotonin/glutamate receptor complex implicated in psychosis

    Article • Nature, February 2008, Springer Science + Business Media

    Dr Luis F Callado

  36. Specific binding of [3H]Ro 19-6327 (lazabemide) to monoamine oxidase B is increased in frontal cortex of suicide victims after controlling for age at death

    Article • European Neuropsychopharmacology, January 2008, Elsevier

    Dr Luis F Callado

  37. On the search of new I2-IBS aliphatic ligands: Bis-guanidino carbonyl derivatives

    Article • Bioorganic & Medicinal Chemistry Letters, November 2007, Elsevier

    Dr Luis F Callado

  38. Synthesis and Pharmacological Evaluation of Chlorinated N‐Alkyl‐3‐ and ‐5‐(2‐hydroxyphenyl)pyrazoles as CB1 Cannabinoid Ligands.

    Article • ChemInform, October 2007, Wiley

    Dr Luis F Callado

  39. Guanidine and 2-Aminoimidazoline Aromatic Derivatives as α2-Adrenoceptor Antagonists, 1:  Toward New Antidepressants with Heteroatomic Linkers

    Article • Journal of Medicinal Chemistry, August 2007, American Chemical Society (ACS)

    Dr Luis F Callado

  40. Synthesis and Pharmacological Evaluation of Chlorinated N-Alkyl-3- and -5-(2-hydroxyphenyl)pyrazoles as CB 1 Cannabinoid Ligands

    Article • Monatshefte für Chemie - Chemical Monthly, May 2007, Springer Science + Business Media

    Dr Luis F Callado, Dr. Nadine jagerovic

  41. An Independent Meta-Analysis Using Summary Data for Clinical Response, Remission, and Discontinuation for Any Reason from the 6 Pivotal Phase III Randomized Clinical Trials of Duloxetine in Major Depressive Disorder

    Article • Journal of Clinical Psychopharmacology, April 2007, Wolters Kluwer Health

    Dr Luis F Callado

  42. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the μ-opioid receptor and I2–imidazoline binding sites

    Article • Bioorganic & Medicinal Chemistry, October 2006, Elsevier

    Dr Luis F Callado, Dr. Nadine jagerovic

  43. Levels of G-protein αq/11 subunits and of phospholipase C-β(1–4), -γ, and -δ1 isoforms in postmortem human brain caudate and cortical membranes: Potential functional implications

    Article • Neurochemistry International, July 2006, Elsevier

    Dr Luis F Callado, Dr Joan Sallés

  44. The N251K functional polymorphism in the α2A-adrenoceptor gene is not associated with depression: a study in suicide completers

    Article • Psychopharmacology, December 2005, Springer Science + Business Media

    Dr Luis F Callado

  45. Opposite changes in Imidazoline I2 receptors and α2-adrenoceptors density in rat frontal cortex after induced gliosis

    Article • Life Sciences, November 2005, Elsevier

    Dr Luis F Callado

  46. Subcellular distribution of membrane-bound aminopeptidases in the human and rat brain

    Article • Neuroscience Letters, July 2005, Elsevier

    Dr Luis F Callado

  47. Differential Postmortem Delay Effect on Agonist-Mediated Phospholipase Cβ Activity in Human Cortical Crude and Synaptosomal Brain Membranes

    Article • Neurochemical Research, July 2004, Springer Science + Business Media

    Dr Luis F Callado, Dr Joan Sallés

  48. Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials

    Article • Journal of Affective Disorders, April 2004, Elsevier

    Dr Luis F Callado

  49. Fentanyl Derivatives Bearing Aliphatic Alkaneguanidinium Moieties: A New Series of Hybrid Molecules with Significant Binding Affinity for μ‐Opioid Receptors and I2‐Imidazoline Binding Sites.

    Article • ChemInform, March 2004, Wiley

    Dr Luis F Callado, Dr. Nadine jagerovic

  50. Fentanyl derivatives bearing aliphatic alkaneguanidinium moieties: a new series of hybrid molecules with significant binding affinity for μ-opioid receptors and I2-imidazoline binding sites

    Article • Bioorganic & Medicinal Chemistry Letters, January 2004, Elsevier

    Dr Luis F Callado, Dr. Nadine jagerovic

  51. Synthesis and opioid activity of new fentanyl analogs

    Article • Life Sciences, July 2002, Elsevier

    Dr Luis F Callado, Dr. Nadine jagerovic, Raquel Abalo

  52. ChemInform Abstract: Guanidinium and Aminoimidazolinium Derivatives of N‐(4‐Piperidyl)propanamides as Potential Ligands for μ Opioid and I2‐Imidazoline Receptors: Synthesis and Pharmacological Screening.

    Article • ChemInform, May 2002, Wiley

    Dr Luis F Callado, Dr. Nadine jagerovic

  53. I 2 -Imidazoline Binding Site Affinity of a Structurally Different Type of Ligands

    Article • Bioorganic & Medicinal Chemistry, May 2002, Elsevier

    Dr Luis F Callado

  54. Altered presynaptic function in monoaminergic neurons of monoamine oxidase‐A knockout mice

    Article • European Journal of Neuroscience, May 2002, Wiley

    Dr Luis F Callado

  55. Guanidinium and aminoimidazolinium derivatives of N-(4-piperidyl)propanamides as potential ligands for μ opioid and I2-imidazoline receptors: synthesis and pharmacological screening

    Article • Bioorganic & Medicinal Chemistry, April 2002, Elsevier

    Dr Luis F Callado, Dr. Nadine jagerovic

  56. Long-Acting Fentanyl Analogues: Synthesis and Pharmacology of N-(1-Phenylpyrazolyl)-N-(1-phenylalkyl-4-piperidyl)propanamides

    Article • Bioorganic & Medicinal Chemistry, March 2002, Elsevier

    Dr Luis F Callado, Dr. Nadine jagerovic, Raquel Abalo

  57. Characterization of [ 3 H]idazoxan binding sites on human platelets

    Article • Platelets, January 2002, Taylor & Francis

    Dr Luis F Callado

  58. Differential [3H]idazoxan and [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) binding to imidazoline I2 receptors in human postmortem frontal cortex

    Article • European Journal of Pharmacology, July 2001, Elsevier

    Dr Luis F Callado

  59. Regulation of phospholipase Cβ activity by muscarinic acetylcholine and 5-HT2 receptors in crude and synaptosomal membranes from human cerebral cortex

    Article • Neuropharmacology, April 2001, Elsevier

    Dr Luis F Callado, Dr Joan Sallés

  60. I2-Imidazoline receptors and monoamine oxidase B enzyme sites in human brain: covariation with age

    Article • Neuroscience Letters, July 2000, Elsevier

    Dr Luis F Callado

  61. Spatiotemporal Interaction of α2 Autoreceptors and Noradrenaline Transporters in the Rat Locus Coeruleus

    Article • Journal of Neurochemistry, June 2000, Wiley

    Dr Luis F Callado

  62. Effects of dizocilpine (MK 801) on noradrenaline, serotonin and dopamine release and uptake

    Article • Neuroreport, January 2000, Wolters Kluwer Health

    Dr Luis F Callado

  63. Differential modulation of α2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment

    Article • Life Sciences, May 1999, Elsevier

    Dr Luis F Callado

  64. α2A- But not α2B/C-adrenoceptors modulate noradrenaline release in rat locus coeruleus: voltammetric data

    Article • European Journal of Pharmacology, January 1999, Elsevier

    Dr Luis F Callado

  65. Selective Increase of α2A‐Adrenoceptor Agonist Binding Sites in Brains of Depressed Suicide Victims

    Article • Journal of Neurochemistry, March 1998, Wiley

    Dr Luis F Callado

  66. The Density of Monoamine Oxidase B Sites Is Not Altered in the Postmortem Brain of Alcoholics

    Article • Alcoholism Clinical and Experimental Research, November 1997, Wiley

    Dr Luis F Callado

  67. Low-affinity conditions for agonists increase the binding of the antagonist []RX821002 to the α2B/C-adrenoceptor subtypes in human brain and rat kidney

    Article • European Journal of Pharmacology, July 1997, Elsevier

    Dr Luis F Callado

  68. Alleged police ill-treatment of non-political detainees in the Basque Country (Spain). Prevalence and associated factors

    Article • Forensic Science International, June 1997, Elsevier

    Dr Luis F Callado

  69. [3H]RX821002 (2-methoxyidazoxan) binds to α2-adrenoceptor subtypes and a non-adrenoceptor imidazoline binding site in rat kidney

    Article • European Journal of Pharmacology, December 1996, Elsevier

    Dr Luis F Callado

  70. The subtype-selective α2-adrenoceptor antagonists BRL 44408 and ARC 239 also recognize 5-HT1A receptors in the rat brain

    Article • European Journal of Pharmacology, October 1996, Elsevier

    Dr Luis F Callado

  71. α2-Adrenoceptor subtypes in the human brain: a pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections

    Article • European Journal of Pharmacology, August 1996, Elsevier

    Dr Luis F Callado

  72. Increased density of I2-imidazoline receptors in human glioblastomas

    Article • Neuroreport, May 1996, Wolters Kluwer Health

    Dr Luis F Callado

  73. Prevalence and methods of torture claimed in the Basque Country (Spain) during 1992–1993

    Article • Forensic Science International, December 1995, Elsevier

    Dr Luis F Callado